Bateman S M, Pidgeon J, Spiro S G, Johnson A J
Br J Clin Pharmacol. 1978 Feb;5(2):127-9. doi: 10.1111/j.1365-2125.1978.tb01612.x.
1 The metabolic effects of salbutamol (5 mg) given by intermittent positive pressure breathing have been studied in eight patients with airflow obstruction. 2 No changes in plasma nonesterified fatty acids, triglyceride, glucose, insulin or cortisol were seen 1 and 4 h after administration. 3 It is concluded that inhaled salbutamol does not cause the unwanted metabolic effects reported with oral or parenteral administration, and that this is a further indication for this route of administration.